Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04902352
What this trial is testing

The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
University Hospital Birmingham NHS Foundation Trust 102
Early research (Phase 1)Looking for participantsNCT06778863
What this trial is testing

CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+8 more
Clasp Therapeutics, Inc. 90
Early research (Phase 1)Not Yet RecruitingNCT07738939
What this trial is testing

IKS04 Regimen in Advanced Solid Tumors That Express CA242

Who this might be right for
Colorectal CancerGastro Esophageal Junctional CancerGastric Cancer (GC)+5 more
Iksuda Therapeutics Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00966706
What this trial is testing

Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 105
Testing effectiveness (Phase 2)WithdrawnNCT05926206
What this trial is testing

Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
University of Michigan Rogel Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00550004
What this trial is testing

Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine

Who this might be right for
Pancreatic Cancer
SciClone Pharmaceuticals 153
Not applicableStudy completedNCT01135849
What this trial is testing

B-Receptor Signaling in Cardiomyopathy

Who this might be right for
CarcinomasAmyloidosisAnal Cancer+35 more
Daniel Bernstein 99
Testing effectiveness (Phase 2)Study completedNCT03717298
What this trial is testing

Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Adenocarcinoma of the PancreasPancreatic CancerAdvanced Cancer+6 more
Catalysis SL 30
Testing effectiveness (Phase 2)Looking for participantsNCT07619521
What this trial is testing

Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage III Pancreatic Cancer AJCC v8+2 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)UnknownNCT03779464
What this trial is testing

Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerNab-paclitaxelGemcitabine+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 132
Early research (Phase 1)Study completedNCT05546853
What this trial is testing

Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Hospital, Grenoble 43
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT04387071
What this trial is testing

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8+1 more
University of Southern California 2
Large-scale testing (Phase 3)Study completedNCT00030732
What this trial is testing

Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Swiss Cancer Institute 319
Testing effectiveness (Phase 2)WithdrawnNCT01130701
What this trial is testing

A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . .

Who this might be right for
Pancreatic Cancer
University of Massachusetts, Worcester
Not applicableStudy completedNCT06378580
What this trial is testing

The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Luo Cong 72
Early research (Phase 1)Looking for participantsNCT07106827
What this trial is testing

GV20-0251 in Advanced or Refractory Solid Tumors

Who this might be right for
HCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more
West China Hospital 10
Not applicableWithdrawnNCT01094535
What this trial is testing

Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery

Who this might be right for
Pancreatic Cancer
Columbia University
Early research (Phase 1)Study completedNCT01048320
What this trial is testing

Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Royal Marsden NHS Foundation Trust 36
Testing effectiveness (Phase 2)Study completedNCT00003332
What this trial is testing

Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health 36
Next Page